APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nociceptin Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nociceptin Receptor Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchNociceptin Receptor Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Nociceptin Receptor Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nociceptin Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nociceptin Receptor Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nociceptin Receptor Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nociceptin Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nociceptin Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nociceptin Receptor market include Serodus ASA, Orexigen Therapeutics Inc, Grunenthal GmbH, Fuso Pharmaceutical Industries Ltd and Blackthorn Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nociceptin Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nociceptin Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nociceptin Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nociceptin Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Nociceptin Receptor Segment by Company

Serodus ASA

Orexigen Therapeutics Inc

Grunenthal GmbH

Fuso Pharmaceutical Industries Ltd

Blackthorn Therapeutics Inc

Nociceptin Receptor Segment by Type

GRTTA-2210

GRT-6010

Cebranopadol

BTRX-246040

AT-403

Others

Nociceptin Receptor Segment by Application

Major Depressive Disorder

Drug Addiction

Diabetic Neuropathic Pain

Postherpetic Neuralgia

Others

Nociceptin Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nociceptin Receptor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nociceptin Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nociceptin Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Nociceptin Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nociceptin Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nociceptin Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nociceptin Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nociceptin Receptor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nociceptin Receptor industry.

Chapter 3: Detailed analysis of Nociceptin Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nociceptin Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nociceptin Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nociceptin Receptor Industry Trends Table 2. Nociceptin Receptor Industry Drivers Table 3. Nociceptin Receptor Industry Opportunities and Challenges Table 4. Nociceptin Receptor Industry Restraints Table 5. Global Nociceptin Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nociceptin Receptor Revenue Share by Company (2021-2026) Table 7. Global Nociceptin Receptor Sales Volume by Company (k units) & (2021-2026) Table 8. Global Nociceptin Receptor Sales Volume Share by Company (2021-2026) Table 9. Global Nociceptin Receptor Average Price (US$/unit) of Company (2021-2026) Table 10. Global Nociceptin Receptor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nociceptin Receptor Key Company Manufacturing Base & Headquarters Table 12. Global Nociceptin Receptor Company, Product Type & Application Table 13. Global Nociceptin Receptor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nociceptin Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of GRTTA-2210 Table 18. Significant Companies of GRT-6010 Table 19. Significant Companies of Cebranopadol Table 20. Significant Companies of BTRX-246040 Table 21. Significant Companies of AT-403 Table 22. Significant Companies of Others Table 23. Global Nociceptin Receptor Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Nociceptin Receptor Sales Volume by Type (2021-2026) & (k units) Table 25. Global Nociceptin Receptor Sales Volume by Type (2027-2032) & (k units) Table 26. Global Nociceptin Receptor Sales Volume Share by Type (2021-2026) Table 27. Global Nociceptin Receptor Sales Volume Share by Type (2027-2032) Table 28. Global Nociceptin Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Nociceptin Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Nociceptin Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Nociceptin Receptor Sales Value Share by Type (2021-2026) Table 32. Global Nociceptin Receptor Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Major Depressive Disorder Table 34. Significant Companies of Drug Addiction Table 35. Significant Companies of Diabetic Neuropathic Pain Table 36. Significant Companies of Postherpetic Neuralgia Table 37. Significant Companies of Others Table 38. Global Nociceptin Receptor Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Nociceptin Receptor Sales Volume by Application (2021-2026) & (k units) Table 40. Global Nociceptin Receptor Sales Volume by Application (2027-2032) & (k units) Table 41. Global Nociceptin Receptor Sales Volume Share by Application (2021-2026) Table 42. Global Nociceptin Receptor Sales Volume Share by Application (2027-2032) Table 43. Global Nociceptin Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Nociceptin Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Nociceptin Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Nociceptin Receptor Sales Value Share by Application (2021-2026) Table 47. Global Nociceptin Receptor Sales Value Share by Application (2027-2032) Table 48. Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 49. Global Nociceptin Receptor Sales by Region (2021-2026) & (k units) Table 50. Global Nociceptin Receptor Sales Market Share by Region (2021-2026) Table 51. Global Nociceptin Receptor Sales by Region (2027-2032) & (k units) Table 52. Global Nociceptin Receptor Sales Market Share by Region (2027-2032) Table 53. Global Nociceptin Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Nociceptin Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Nociceptin Receptor Sales Value Share by Region (2021-2026) Table 56. Global Nociceptin Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Nociceptin Receptor Sales Value Share by Region (2027-2032) Table 58. Global Nociceptin Receptor Market Average Price (US$/unit) by Region (2021-2026) Table 59. Global Nociceptin Receptor Market Average Price (US$/unit) by Region (2027-2032) Table 60. Global Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 61. Global Nociceptin Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 63. Global Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 64. Global Nociceptin Receptor Sales by Country (2027-2032) & (k units) Table 65. Global Nociceptin Receptor Sales Market Share by Country (2027-2032) Table 66. Global Nociceptin Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Nociceptin Receptor Sales Value Market Share by Country (2021-2026) Table 68. Global Nociceptin Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Nociceptin Receptor Sales Value Market Share by Country (2027-2032) Table 70. Serodus ASA Company Information Table 71. Serodus ASA Business Overview Table 72. Serodus ASA Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Serodus ASA Nociceptin Receptor Product Portfolio Table 74. Serodus ASA Recent Development Table 75. Orexigen Therapeutics Inc Company Information Table 76. Orexigen Therapeutics Inc Business Overview Table 77. Orexigen Therapeutics Inc Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio Table 79. Orexigen Therapeutics Inc Recent Development Table 80. Grunenthal GmbH Company Information Table 81. Grunenthal GmbH Business Overview Table 82. Grunenthal GmbH Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Grunenthal GmbH Nociceptin Receptor Product Portfolio Table 84. Grunenthal GmbH Recent Development Table 85. Fuso Pharmaceutical Industries Ltd Company Information Table 86. Fuso Pharmaceutical Industries Ltd Business Overview Table 87. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio Table 89. Fuso Pharmaceutical Industries Ltd Recent Development Table 90. Blackthorn Therapeutics Inc Company Information Table 91. Blackthorn Therapeutics Inc Business Overview Table 92. Blackthorn Therapeutics Inc Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio Table 94. Blackthorn Therapeutics Inc Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Nociceptin Receptor Distributors List Table 98. Nociceptin Receptor Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Nociceptin Receptor Product Image Figure 2. Global Nociceptin Receptor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nociceptin Receptor Sales (2021-2032) & (k units) Figure 5. Global Nociceptin Receptor Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Nociceptin Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. GRTTA-2210 Image Figure 10. GRT-6010 Image Figure 11. Cebranopadol Image Figure 12. BTRX-246040 Image Figure 13. AT-403 Image Figure 14. Others Image Figure 15. Global Nociceptin Receptor Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Nociceptin Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Nociceptin Receptor Sales Volume Share by Type (2021-2032) Figure 18. Global Nociceptin Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Nociceptin Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Nociceptin Receptor Sales Value Share by Type (2021-2032) Figure 21. Major Depressive Disorder Image Figure 22. Drug Addiction Image Figure 23. Diabetic Neuropathic Pain Image Figure 24. Postherpetic Neuralgia Image Figure 25. Others Image Figure 26. Global Nociceptin Receptor Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Nociceptin Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Nociceptin Receptor Sales Volume Share by Application (2021-2032) Figure 29. Global Nociceptin Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Nociceptin Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Nociceptin Receptor Sales Value Share by Application (2021-2032) Figure 32. Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 33. Global Nociceptin Receptor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Nociceptin Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Nociceptin Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 37. North America Nociceptin Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Nociceptin Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Nociceptin Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 43. South America Nociceptin Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Nociceptin Receptor Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Nociceptin Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Nociceptin Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Nociceptin Receptor Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Nociceptin Receptor Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • GRTTA-2210
  • GRT-6010
  • Cebranopadol
  • BTRX-246040
  • AT-403
  • Others
Applications
  • Major Depressive Disorder
  • Drug Addiction
  • Diabetic Neuropathic Pain
  • Postherpetic Neuralgia
  • Others
Companies covered
  • Serodus ASA
  • Orexigen Therapeutics Inc
  • Grunenthal GmbH
  • Fuso Pharmaceutical Industries Ltd
  • Blackthorn Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nociceptin Receptor Sales Value (2021-2032)
  4. 1.2.2 Global Nociceptin Receptor Sales Volume (2021-2032)
  5. 1.2.3 Global Nociceptin Receptor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nociceptin Receptor Market Dynamics
  1. 2.1 Nociceptin Receptor Industry Trends
  2. 2.2 Nociceptin Receptor Industry Drivers
  3. 2.3 Nociceptin Receptor Industry Opportunities and Challenges
  4. 2.4 Nociceptin Receptor Industry Restraints
3 Nociceptin Receptor Market by Company
  1. 3.1 Global Nociceptin Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Nociceptin Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Nociceptin Receptor Sales Volume by Company (2021-2026)
  4. 3.4 Global Nociceptin Receptor Average Price by Company (2021-2026)
  5. 3.5 Global Nociceptin Receptor Company Ranking (2024-2026)
  6. 3.6 Global Nociceptin Receptor Company Manufacturing Base and Headquarters
  7. 3.7 Global Nociceptin Receptor Company Product Type and Application
  8. 3.8 Global Nociceptin Receptor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nociceptin Receptor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nociceptin Receptor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nociceptin Receptor Market by Type
  1. 4.1 Nociceptin Receptor Type Introduction
  2. 4.1.1 GRTTA-2210
  3. 4.1.2 GRT-6010
  4. 4.1.3 Cebranopadol
  5. 4.1.4 BTRX-246040
  6. 4.1.5 AT-403
  7. 4.1.6 Others
  8. 4.2 Global Nociceptin Receptor Sales Volume by Type
  9. 4.2.1 Global Nociceptin Receptor Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Nociceptin Receptor Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Nociceptin Receptor Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Nociceptin Receptor Sales Value by Type
  13. 4.3.1 Global Nociceptin Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Nociceptin Receptor Sales Value by Type (2021-2032)
  15. 4.3.3 Global Nociceptin Receptor Sales Value Share by Type (2021-2032)
5 Nociceptin Receptor Market by Application
  1. 5.1 Nociceptin Receptor Application Introduction
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Drug Addiction
  4. 5.1.3 Diabetic Neuropathic Pain
  5. 5.1.4 Postherpetic Neuralgia
  6. 5.1.5 Others
  7. 5.2 Global Nociceptin Receptor Sales Volume by Application
  8. 5.2.1 Global Nociceptin Receptor Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nociceptin Receptor Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Nociceptin Receptor Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Nociceptin Receptor Sales Value by Application
  12. 5.3.1 Global Nociceptin Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nociceptin Receptor Sales Value by Application (2021-2032)
  14. 5.3.3 Global Nociceptin Receptor Sales Value Share by Application (2021-2032)
6 Nociceptin Receptor Regional Sales and Value Analysis
  1. 6.1 Global Nociceptin Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nociceptin Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Nociceptin Receptor Sales by Region: 2021-2026
  4. 6.2.2 Global Nociceptin Receptor Sales by Region (2027-2032)
  5. 6.3 Global Nociceptin Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nociceptin Receptor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nociceptin Receptor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nociceptin Receptor Sales Value by Region (2027-2032)
  9. 6.5 Global Nociceptin Receptor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nociceptin Receptor Sales Value (2021-2032)
  12. 6.6.2 North America Nociceptin Receptor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nociceptin Receptor Sales Value (2021-2032)
  15. 6.7.2 Europe Nociceptin Receptor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nociceptin Receptor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nociceptin Receptor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nociceptin Receptor Sales Value (2021-2032)
  21. 6.9.2 South America Nociceptin Receptor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nociceptin Receptor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nociceptin Receptor Sales Value Share by Country, 2025 VS 2032
7 Nociceptin Receptor Country-level Sales and Value Analysis
  1. 7.1 Global Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nociceptin Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nociceptin Receptor Sales by Country (2021-2032)
  4. 7.3.1 Global Nociceptin Receptor Sales by Country (2021-2026)
  5. 7.3.2 Global Nociceptin Receptor Sales by Country (2027-2032)
  6. 7.4 Global Nociceptin Receptor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nociceptin Receptor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nociceptin Receptor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nociceptin Receptor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nociceptin Receptor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nociceptin Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Serodus ASA
  2. 8.1.1 Serodus ASA Company Information
  3. 8.1.2 Serodus ASA Business Overview
  4. 8.1.3 Serodus ASA Nociceptin Receptor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Serodus ASA Nociceptin Receptor Product Portfolio
  6. 8.1.5 Serodus ASA Recent Developments
  7. 8.2 Orexigen Therapeutics Inc
  8. 8.2.1 Orexigen Therapeutics Inc Company Information
  9. 8.2.2 Orexigen Therapeutics Inc Business Overview
  10. 8.2.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio
  12. 8.2.5 Orexigen Therapeutics Inc Recent Developments
  13. 8.3 Grunenthal GmbH
  14. 8.3.1 Grunenthal GmbH Company Information
  15. 8.3.2 Grunenthal GmbH Business Overview
  16. 8.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Grunenthal GmbH Nociceptin Receptor Product Portfolio
  18. 8.3.5 Grunenthal GmbH Recent Developments
  19. 8.4 Fuso Pharmaceutical Industries Ltd
  20. 8.4.1 Fuso Pharmaceutical Industries Ltd Company Information
  21. 8.4.2 Fuso Pharmaceutical Industries Ltd Business Overview
  22. 8.4.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio
  24. 8.4.5 Fuso Pharmaceutical Industries Ltd Recent Developments
  25. 8.5 Blackthorn Therapeutics Inc
  26. 8.5.1 Blackthorn Therapeutics Inc Company Information
  27. 8.5.2 Blackthorn Therapeutics Inc Business Overview
  28. 8.5.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio
  30. 8.5.5 Blackthorn Therapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nociceptin Receptor Value Chain Analysis
  2. 9.1.1 Nociceptin Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nociceptin Receptor Sales Mode & Process
  6. 9.2 Nociceptin Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nociceptin Receptor Distributors
  9. 9.2.3 Nociceptin Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst